Tennessee
How Association for Molecular Pathology v. Myriad Genetics, Inc. applies in Tennessee: state-specific rules, key cases, and bar exam notes for Intellectual Property (Patent Law).
Tennessee law follows the principles established by the Supreme Court in Association for Molecular Pathology v. Myriad Genetics, Inc., emphasizing that naturally occurring genes are not patentable. The state reinforces the notion that the mere discovery of a natural phenomenon does not qualify for patent protection.
In Tennessee, as per federal guidelines reaffirmed by the case, naturally occurring genetic sequences and their functions cannot be patented unless they are significantly altered to create a new and useful invention.
The court held that isolated human genes cannot be patented in Tennessee, aligning with federal precedent on natural products.
This case reiterated that abstract ideas and natural phenomena do not constitute patentable subject matter under Tennessee law.
The ruling confirmed that the isolation of genes, without further innovation, does not meet the patent eligibility requirements established in Tennessee.
Tennessee adheres closely to the federal standard set forth by the Supreme Court in Myriad, with no state-specific deviations on the patentability of natural products. Both state and federal laws align in their rejection of patents on unmodified natural genes.
Understanding the implications of Myriad is essential for Tennessee bar examinees, particularly in relation to patent eligibility involving natural products and discoveries.